NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for USA stock CUE Cue Biopharma. Dated: 30 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 0.35 and Closed at: 0.33, which is -9.09% of previous session's close. It moved within a range of 0.33 and 0.37
The session was a Bearish session with an average volume of 723400, which is 60.33% of previous session's volumes.

A Dead cross was found 4 days back on short term averages

Support for tomorrow is 0.31 and resistance for tomorrow is 0.35
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.32, 0.3 resistance for tomorrow's hourly charts is 0.36, 0.38

10 Day SMA for Cue Biopharma (CUE) is 0.35 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 0.35 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 0.42 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 0.58 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Cue Biopharma is 0.67 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Cue Biopharma is at 0.35 and 200 DMA is at 0.67, while 50 DMA and 100 DMA are at 0.42 and 0.58 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 0.35 and 20 EMA is at 0.35

Cue Biopharma (CUE) moving average of 50 SMA is at 0.42 and 50 EMA is at 0.43

Cue Biopharma (CUE) moving average of 100 SMA is at 0.58 and 100 EMA is at 0.56

Cue Biopharma (CUE) moving average of 200 SMA is at 0.67 and 200 EMA is at 0.81

Stryker Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Stryker Corporation, about 9.08% more returns!

Hca Healthcare has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Hca Healthcare, about 6.74% more returns!

Quest Diagnostics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Quest Diagnostics, about 10.56% more returns!

Sutro Biopharma has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Sutro Biopharma, about 39.35% more returns!

Cue Biopharma has performed better than Syndax Pharmaceuticals in short term. Holding Cue Biopharma could be a better choice for now!

Cue Biopharma has performed better than Repligen Corporation in short term. Holding Cue Biopharma could be a better choice for now!

Opko Health has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Opko Health, about 2.15% more returns!

Cue Biopharma has performed better than Neurocrine Biosciences in short term. Holding Cue Biopharma could be a better choice for now!

Orthopediatrics Corp has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 2.37% more returns!

Immucell Corporation has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Immucell Corporation, about 4.63% more returns!

Cue Biopharma has performed better than Galectin Therapeutics in short term. Holding Cue Biopharma could be a better choice for now!

Fennec Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 1.77% more returns!

Cue Biopharma has performed better than Evolus Inc in short term. Holding Cue Biopharma could be a better choice for now!

Electrocore Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Electrocore Inc, about 49.31% more returns!

Cue Biopharma has performed better than Atossa Genetics in short term. Holding Cue Biopharma could be a better choice for now!

Ascendis Pharma has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ascendis Pharma, about 8.95% more returns!

Cue Biopharma has performed better than Adma Biologics in short term. Holding Cue Biopharma could be a better choice for now!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Cue Biopharma in short term but the buy signal is initial and weak.

Cue Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Cue Biopharma in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Cue Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.36 and Cue Biopharma CUE stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet